A recent study focusing on KEAP1-mutant non-small cell lung cancer (NSCLC) found that FSP1 expression was partially dependent on NRF2 [63], though NRF2 inhibition alone did not significantly reduce FSP1 protein levels. Here, NFE2L2 is linked to non-small cell lung carcinoma.